Key Takeaways
- • New York City venture capital funding reached $4.70 billion across 81 companies in June 2026, the highest monthly total on record and more than double May's $2.30 billion, driven by unusual depth rather than a single outsized deal.
- • Frontier AI research labs emerged as a defining trend, with Flourish raising $500 million at its stealth exit backed by Jeff Bezos, Lux Capital, and GV, and General Intuition securing $320 million from Khosla Ventures—both establishing major R&D operations in New York.
- • Ramp led the month's mega-rounds with a $750 million Series C at a $44 billion valuation, while 12 rounds exceeded $100 million (up from seven in May), with the top 10 deals capturing 68.1% of total capital deployed.
- • NYC captured 24.4% of all U.S. venture dollars in June, its highest national share in at least one year, climbing from 3.0% in May and exceeding the previous high-water mark of 21.6% set in July 2025.
- • Series B activity contracted sharply, with only four rounds totaling $205 million in June versus nine deals worth $454.9 million in May, signaling a shift toward larger institutional rounds at both early and late stages.
Summary
The month's defining narrative centered on frontier artificial intelligence research laboratories establishing major operations in New York. Flourish, emerging from stealth, closed a $500 million Series A backed by Jeff Bezos, Lux Capital, and Google Ventures to develop brain-inspired AI models from a ten-story SoHo facility. Simultaneously, General Intuition announced a $320 million financing from Khosla Ventures to train action models using gameplay data. These two mega-rounds planted meaningful R&D infrastructure in Manhattan and signaled a competitive shift in early-stage AI model development away from traditional West Coast clusters.
Beyond the frontier AI story, Ramp led the month's conventional mega-rounds with a $750 million Series C at a $44 billion valuation, demonstrating sustained investor confidence in fintech infrastructure despite macroeconomic volatility. The concentration of mega-rounds intensified: 12 deals exceeded $100 million in June, compared to seven in May, reflecting both larger check sizes and fewer sub-$100 million transactions completing in the period.
New York's competitive positioning strengthened materially, capturing 24.4% of all U.S. venture capital in June—the highest share in at least one year and a dramatic climb from 3.0% in May. This metric surpassed the previous 12-month high of 21.6% established in July 2025, suggesting sustained institutional capital reallocation toward the New York ecosystem. However, early-stage activity showed stress signals: Series B funding collapsed to four rounds totaling $205 million, down sharply from May's nine deals worth $454.9 million, indicating a potential bifurcation between well-capitalized growth-stage companies and earlier cohorts facing tightened early institutional funding.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.